 Home > Biochemistry News > Biotechnology News > Specific pancreatic cancer remission rate is 42%. Initial clinical results of innovative bispecific antibody therapy are positive

Specific pancreatic cancer remission rate is 42%. Initial clinical results of innovative bispecific antibody therapy are positive

 Last Update: 2021-06-22
 Source: Internet
 Author: User

Tags

1 4 cyclohexadiene

oneneck data center

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

A few days ago, Merus announced the latest clinical trial results of its research bispecific antibody therapy zenocutuzumab at the ASCO annual meeting

In patients with NRG1 fusion-positive tumors, the NRG1 gene that expresses neuregulin is fused with other genes, resulting in abnormal expression of neuregulin, which promotes the occurrence and proliferation of cancer

In addition, this antibody also has the effect of enhancing antibody-dependent cell-mediated cytotoxicity (ADCC), thereby improving the killing of tumors by immune cells

▲The mechanism of action of Zenocutuzumab (picture source: Merus official website)

The results reported by ASCO included a total of 45 patients with NRG1 fusion-positive solid tumors whose results could be evaluated.

Note: The original text has been deleted

Reference materials:

[1] Merus Presents Clinical Data on Zenocutuzumab in NRG1-fusion (NRG1+) Cancers at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting (Oral Abstract).

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.